CO-D Therapeutics
Madison, US · Wisconsin corporation
Founders & leadership
GS
Glen S. KwonNamed on SEC filing
KR
Kevin R. KozakNamed on SEC filing
PV
Paul V. RadspinnerNamed on SEC filing
AA
Abdalla A. SaadNamed on SEC filing
JP
J. Patrick GennNamed on SEC filing
AS
Alex S. KimNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$428K disclosed across 1 round · 2015
▶$428KraisedNov 2018 · 16 investors · Other Health CareRule 506(b)
▶$428KraisedNov 2018 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Glen S. KwonExecutive Officer, Director
- Kevin R. KozakExecutive Officer, Director
- Paul V. RadspinnerDirector
- Abdalla A. SaadExecutive Officer, Director
- J. Patrick GennDirector
- Alex S. KimDirector
- Offering amount
- $528K
- Amount sold
- $428K
- First sale
- Dec 2015
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has CO-D Therapeutics raised?
- CO-D Therapeutics has disclosed $428K raised across 1 round.
- Where is CO-D Therapeutics headquartered?
- CO-D Therapeutics is headquartered in Madison, US.